CervoMed Inc (CRVO)
NASDAQ
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -96.449 | -11.996 | -120.069 | -55.77 | -62.252 | -73.495 | -51.563 | -13.322 |
Return on Equity (%) | -140.777 | -17.209 | -144.531 | -66.016 | -71.799 | -80.686 | -56.562 | -15.742 |
Return on Invested Capital (%) | -132.36 | -40.824 | -66.663 | -65.773 | -71.618 | -53.731 | -57.96 | -56.635 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -30.399 |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -30.399 |
Book Value Per Share | -0.616 | 0.389 | 2.051 | 0.343 | 0.253 | 0.342 | 9.838 | 1.296 |
Earnings Per Share | -1.739 | -0.18 | -7.831 | -0.352 | -0.252 | -0.236 | -7.587 | -0.382 |
Cash Per Share | 0.15 | 0.612 | 2.35 | 0.423 | 0.289 | 0.366 | 4.922 | 1.369 |
Working Capital Per Share | -0.273 | 0.48 | 2.385 | 0.386 | 0.255 | 0.342 | 9.838 | 1.295 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 1.255 |
EBIT Per Share | -1.774 | -0.166 | -5.531 | -0.342 | -0.248 | -0.241 | -7.587 | -0.382 |
EBITDA Per Share | -1.774 | -0.166 | -5.531 | -0.342 | -0.248 | -0.241 | -7.587 | -0.382 |
Free Cash Flow Per Share | -1.742 | -0.154 | -7.863 | -0.355 | -0.254 | -0.237 | -7.587 | -0.382 |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 10.35M | 14.52M | 3.38M | 33.48M | 64.02M | 101.91M | 2.04M | N/A |
Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | 2.04M | 2.04M | 2.04M | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | -107.115 | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | -107.115 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 19.07M |
Price to Earnings Ratio | -16.72 |
Price to Sales Ratio | 5.08 |
Price to Cash Ratio | 4.66 |
Price to Book Ratio | 4.92 |
Dividend Yield | - |
Shares Outstanding | 8.25M |
Average Volume (1 week) | 294.25k |
Average Volume (1 Month) | 660.93k |
52 Week Change | -76.56% |
52 Week High | 26.3789 |
52 Week Low | 1.80 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.